Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.

In a clinicohistopathologic study of 557 patients with primary cutaneous malignant melanoma, there were fewer metastases and/or deaths from melanoma when histologic evidence of a coexisting acquired melanocytic nevus was found. A total of 130 patients with melanocytic nevus and 427 cases of melanoma without histologic evidence of a nevus (denovo) were studied. Clinical follow-up evaluation for evidence of metastases and/or death was obtained. Only ten of the patients (7.7%) with nevus-associated melanoma had metastases and/or death v 78 (18.3%) with de novo melanoma. When stratified by lesion thickness, the logrank test for survival revealed a statistically significant difference between the two groups. An overall favorable outcome seen in patients with malignant melanomas associated with acquired melanocytic nevi was found, therefore, to be independent of lesion thickness as well as six other variables reported to be related to the biologic behavior of malignant melanoma. Thus, the presence of nevus cells in a specimen of malignant melanoma portends a better prognosis and may have important implications in the biology of this neoplasm.

[1]  M C Mihm,et al.  Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes , 1981, Cancer.

[2]  M. Mihm,et al.  A Prognostic Model for Clinical Stage I Melanoma of the Upper Extremity. The Importance of Anatomic Subsites in Predicting Recurrent Disease , 1981, Annals of surgery.

[3]  J. H. Little,et al.  Primary cutaneous melanoma: A report from the queensland melanoma project , 1976, CA: a cancer journal for clinicians.

[4]  W. Clark,et al.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.

[5]  C. Balch,et al.  A Multifactorial Analysis of Melanoma: Prognostic Histopathological Features Comparing Clark's and Breslow's Staging Methods , 1978, Annals of surgery.

[6]  G. Todaro,et al.  Human melanoma cells have both nerve growth factor and nerve growth factor-specific receptors on their cell surfaces. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Roberts,et al.  Malignant melanoma of the skin: prognostic value of clinical features and the role of treatment in 111 cases. , 1968, British Journal of Cancer.

[8]  C. Balch.  Surgical management of regional lymph nodes in cutaneous melanoma. , 1980, Journal of the American Academy of Dermatology.

[9]  W. Clark,et al.  Common and uncommon melanocytic nevi and borderline melanomas. , 1975, Seminars in oncology.

[10]  J. H. Little,et al.  RESULTS OF TREATMENT OF 361 PATIENTS WITH MALIGNANT MELANOMA IN QUEENSLAND , 1971, The Medical journal of Australia.

[11]  A Breslow,et al.  Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma , 1970, Annals of surgery.

[12]  H. Wanebo,et al.  Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage) , 1975, Cancer.

[13]  G. Lipkin,et al.  A diffusible factor restoring contact inhibition of growth to malignant melanocytes. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Hou‐Jensen,et al.  [Histology and prognosis in cutaneous malignant melanoma]. , 1977, Ugeskrift for laeger.

[15]  W. Clark,et al.  Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies. , 1973, Human pathology.

[16]  Second Edition,et al.  Statistical Package for the Social Sciences , 1970 .

[17]  A. Huvos,et al.  Prognostic factors in cutaneous malignant melanoma. A comparative study of long term and short term survivors. , 1974, Human pathology.

[18]  H. Bingham,et al.  Malignant melanoma patients with positive nodes and relatively good prognosis , 1981 .